STAT+: As Takeda buys Maverick for up to $525 million, R&D chief promises an ‘inflection year’
Takeda on Tuesday announced that it is buying Maverick Therapeutics for as much as $525…
Author: STAT
STAT+: Is a leaderless FDA clamping down on drug reviews? Not knowing is weighing heavy on biotech
Seemingly overnight, the Food and Drug Administration appears to be taking a more risk-averse stance…
Meghan Markle described racism as a toxic stressor during her pregnancy. I can relate
Megan Markle made the difficult confession that she experienced suicidal thoughts while pregnant with her…
Opinion: Barriers keep many primary care practices from vaccinating seniors
When news first broke in mid-December 2020 that the FDA had issued an emergency use…
STAT+: With data on a cancer drug derived from red blood cells looming, Rubius Therapeutics seeks to shed its bumbling image
Rubius Therapeutics is the can’t-do-anything-right biotech spinout from the high-profile venture capital firm Flagship Pioneering….
With the ear of Joe Manchin, West Virginia hospitals helped secure billions in new Covid relief funds
WASHINGTON — West Virginia University Health System doesn’t have the name recognition of the Mayo…
STAT+: Biden’s silence on an FDA nominee underscores how tough it is to fill that job
WASHINGTON — Nearly everyone here expected President Biden to move with record speed to nominate…
STAT+: Drug makers urge Biden to reject proposal to waive patent rights on Covid-19 products
More than two dozen of the largest pharmaceutical companies are urging President Biden to reject…
STAT+: FDA reviews accelerated approvals as two drug makers withdraw bladder cancer indications
For the second time in less than a month, a drug maker has pulled an…
CDC says fully vaccinated Americans can spend time together indoors and unmasked
WASHINGTON — People who have been fully vaccinated against Covid-19 can now spend time together…
STAT+: Pharmalittle: Merck says early data shows pill is effective against Covid-19; WHO’s COVAX program ships first doses
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Opinion: STAT+: Making pharma’s post-Covid-19 future faster and smarter
There’s nothing like a global pandemic to force a reimagining of one’s business. What it…
A pandemic expert weighs in on the long road ahead for Covid-19 vaccine distribution
Though nearly 300 million doses of Covid-19 vaccines have been administered around the globe so…
Watch: From Kalamazoo to Fenway Park: the logistics of Covid-19 vaccine shipments
Covid-19 vaccinations in the Unites States are starting to accelerate after a slow rollout. The…
STAT+: ‘We are on a collision course’: As virtual care booms, experts call for new health data privacy protections
A drop in your daily step count. A missed period. A loss of hearing. If…
Will the U.S. have Covid vaccine doses for everyone by the end of May? Probably
President Biden confidently declared last week that there would be enough Covid-19 vaccine delivered to…
STAT+: Inside the fall of Watson Health: How IBM’s audacious plan to ‘change the face of health care’ with AI fell apart
It was a summer day in 2018, and the outlook could hardly have seemed more…
STAT+: CytoDyn’s wild weekend of data-mining study results ends in failure for its Covid treatment
Results from a late-stage clinical trial released late Friday by the drug maker CytoDyn showed…
Opinion: Don’t let bureaucracy constrict the supply of Covid-19 vaccines
Vaccination, particularly for the most vulnerable Americans, is the surest way for us to overcome…
Senate approves $1.9 trillion coronavirus relief bill
WASHINGTON (AP) — An exhausted Senate narrowly approved a $1.9 trillion Covid-19 relief bill Saturday…
FDA authorizes new test, built with machine learning, to detect past Covid-19 infections
The Food and Drug Administration on Friday issued an emergency authorization for a new test…
At least 4 founders of Time’s Up Healthcare resign as organization mum on sexual harassment suit
At least four founding members of Time’s Up Healthcare resigned Thursday from the organization following…
STAT+: Lawmakers rail against huge tax breaks drug wholesalers get from opioid settlement
Three congressional lawmakers are examining the extent to which pharmaceutical wholesalers and a leading drug…
‘This isn’t done’: Experts warn that no matter what our Covid end goal is, we have a ways to go
One year after an epidemiologist, a preparedness expert, and an infectious disease journalist presciently warned…
STAT+: European Commission probes Teva for allegedly using patents to thwart competition
In its latest bid to ensure competition among drug makers, the European Commission has opened…
.jpg)
STAT+: Pharmalittle: Serum CEO warns of shortage of vaccine components; EU to extend Covid-19 export scheme
And so, another working week will soon draw to a close. Not a moment too…
Opinion: Covid-19 could bring a new era of public health leadership. But will it?
The bubonic plague — also known as the Black Death — killed as many as…
Opinion: Using the new Johnson & Johnson Covid-19 vaccine to create equity and trust
The Food and Drug Administration’s recent approval of Johnson & Johnson’s Covid-19 vaccine for emergency…
STAT+: What to look for in Lilly’s eagerly awaited Alzheimer’s data
Earlier this year, amid the increasingly bruising debate over Biogen’s controversial treatment for Alzheimer’s disease,…
STAT+: ‘We’re only going to cure diseases if we understand them’: Whitehead director advocates for basic science
Ruth Lehmann became director of the Whitehead Institute for Biomedical Research in July 2020. That…
Listen: Peace among the pharma giants, the next phase of the pandemic, & a little Covid-19 optimism
Can pharma get along post-pandemic? How will we know when the Covid-19 crisis is over?…
STAT+: Physician and patients may prefer brand-name drugs, but they cost Medicare Part D a lot of money
Generic drugs may remain lower-cost alternatives to brand-name medicines, but the Medicare Part D program…
STAT+: Amgen spends $1.9 billion on Five Prime, eyeing an expansion in Asia
Amgen said Thursday it will purchase Five Prime Therapeutics for $1.9 billion to obtain a…
.jpg)
STAT+: Pharmalittle: Novartis to help make CureVac Covid-19 vaccine; U.K. to speed vaccine approvals for Covid-19 variants
Top of the morning to you. Gray skies are hovering over the Pharmalot campus right…
STAT+: Kronos Bio speeds development of genetically targeted leukemia drug with unique trial design
Kronos Bio said Thursday that it had reached an agreement with the Food and Drug…
STAT+: Eli Lilly’s experimental diabetes drug reduced weight and blood sugar in clinical trial
Eli Lilly said Thursday that a study showed its experimental diabetes drug, tirzepatide, reduced patients’…
STAT+: FDA releases a new plan to bring its data skills up to speed
When Ram Iyer started his new job at the Food and Drug Administration in 2020,…
Opinion: For early testing of convalescent plasma, we were ‘building the plane while we were flying it’
During the Covid-19 pandemic, clinicians have seen many remarkable things. Among them is how a…
The short-term, middle-term, and long-term future of the coronavirus
When experts envision the future of the coronavirus, many predict that it will become a…
In Palm Beach, Covid-19 vaccines intended for rural Black communities are instead going to wealthy white Floridians
PAHOKEE, Fla. — The winds blew southwest the day of Pahokee’s Covid-19 vaccination drive, which…
STAT+: Health care industry scores lobbying wins in Senate on drug pricing, provider funds, insurance subsidies
WASHINGTON — Health care industry lobbying groups are poised to score big wins in the…
STAT+: South Africa official explains why world trade rules should be waived to fight Covid-19
Last fall, the governments of India and South Africa asked the World Trade Organization to…
Opinion: Listen: Haider Warraich on hospitals and their communities, yellow berets, and more
In this episode of STAT’s “First Opinion Podcast,” I talk with Haider Warraich, a physician,…
STAT+: Pharmalittle: A race is on to find alternatives to syringes and needles for vaccines; FDA under pressure to inspect more plants
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
STAT+: Ovid sells off its lead drug to double down on neuro research
Ovid Therapeutics, months removed from a crushing clinical trial disappointment, said Wednesday that it is…
Beauty at the micro-scale: MIT’s 2021 images award winners
Much of the world’s focus has been on health care at a global scale this…
Opinion: The Biden administration’s pandemic agenda must not ignore superbugs
What if another devastating pandemic came on the heels of Covid-19? Unfortunately, that looks increasingly…
Freight pilots are flying Covid-19 vaccines around the world — and calling for their turn to be vaccinated
Thousands of UPS and FedEx pilots have flown around the globe for months to deliver…
STAT+: Apple Watch research plows ahead, revealing the device’s health potential
Apple has marketed its Watch for years as a tool to monitor and improve your…
Opinion: CRISPR rivals put patents aside to help in fight against Covid-19
In early January 2020, Feng Zhang, a gene-editing researcher at the Broad Institute of MIT…